Keyphrases
Heart Failure with Preserved Ejection Fraction (HFpEF)
93%
Heart Failure
86%
Patients with Heart Failure
48%
Spironolactone
31%
Confidence Interval
28%
Hazard Ratio
27%
Cardiac Function
26%
Heart Failure Hospitalization
26%
TOPCAT Trial
25%
Chronic Heart Failure
24%
Cardiovascular Mortality
21%
TOPCAT
20%
Aldosterone Antagonists
20%
Adverse Outcomes
18%
Ventricular Assist Device
18%
Dilated Cardiomyopathy
17%
Clinical Outcomes
16%
Ejection Fraction
15%
Left Ventricular Ejection Fraction
15%
Acute Decompensated Heart Failure
13%
Preserved Ejection Fraction
12%
Precision Medicine
11%
Older Adults
10%
COVID-19
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Prognostic Importance
10%
Advanced Heart Failure Therapies
10%
Placebo
9%
All-cause Mortality
9%
Heart Failure Patients
9%
Atrial Fibrillation
9%
Frailty
9%
Heart Transplant
9%
Left Ventricular Assist Device
9%
Heart Rate
8%
Cardiac Structure
8%
Aborted Cardiac Arrest
8%
Vericiguat
8%
PARAGON-HF
7%
Influenza Vaccination
7%
Affordable Care Act Medicaid Expansion
7%
White People
7%
Clinical Trials
7%
B-type Natriuretic Peptide
7%
Cardiovascular Outcomes
7%
Hospitalization
7%
Proband
7%
Influenza Vaccine
7%
Diastolic Function
7%
First-degree Relatives
7%
Medicine and Dentistry
Heart Failure
100%
Heart Failure with Preserved Ejection Fraction
43%
Cardiovascular System
26%
Hazard Ratio
19%
Aldosterone Antagonist
16%
Ventricular Assist Device
15%
Adverse Outcome
14%
Ejection Fraction
13%
Heart Function
13%
Spironolactone
11%
Symptom
10%
Dilated Cardiomyopathy
10%
Personalized Medicine
10%
Heart Transplantation
9%
Clinical Trial
9%
Left Ventricular Assist Device
9%
Diastolic Function
9%
Quality of Life
8%
Systolic Function
8%
Disease
8%
Heart Graft
8%
Brain Natriuretic Peptide
7%
Systolic Heart Failure
7%
Biological Marker
7%
Decision Making
6%
Left Ventricular Hypertrophy
6%
Transplantation
6%
Echocardiography
6%
Heart Arrest
5%
Proteomics
5%
Systolic Blood Pressure
5%
Combination Therapy
5%
Outpatient
5%
Frailty
5%
Ischemic Heart Disease
5%
Influenza Vaccination
5%
Advanced Therapy
5%
Cardiac Resynchronization Therapy
5%
Disease Severity
5%
Heart Left Ventricle Ejection Fraction
5%
Placebo
5%